OpGen
Gaithersburg, US · Delaware corporation · 2 known investors
The page announces the launch of a new fintech arm called CapForce. No further detail about the company's core business is provided on the page.
Founders & leadership
EJ
Evan JonesFounder
VS
Vadim SapiroExecutive
CE
C. Eric WinzerExecutive
DH
David HoekzemaExecutive
TW
Terry WalkerExecutive
CD
C. Douglas WhiteExecutive
Board
BG
Brian G. AtwoodBoard director
BS
Bijan SalehizadehBoard director
RW
Ronald W. LennoxBoard director
CM
Corey MulloyBoard director
MU
Misti UshioBoard director
TH
Timothy HoweBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$65M disclosed across 13 of 14 rounds · 2011–2024
▶$3.4MraisedOct 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3.4MraisedOct 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johannes BacherExecutive Officer
- William E. Rhodes IIIDirector
- Prabhavathi FernandesDirector
- R. Donald ElseyDirector
- Mario CrovettoDirector
- Albert WeberExecutive Officer
- Oliver SchachtExecutive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- Sales commissions
- $202.9K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedFeb 2021 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedFeb 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William E. Rhodes IIIDirector
- Mario CrovettoDirector
- Oliver SchachtExecutive Officer
- Evan JonesDirector
- Prabhavathi FernandesDirector
- Johannes BacherExecutive Officer
- Timothy C. DecExecutive Officer
- R. Donald ElseyDirector
- Offering amount
- $25M
- Amount sold
- $25M
- Sales commissions
- $1.5M
- Placement agents
- Alliance Global Partners
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedDec 2020 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedDec 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johannes BacherExecutive Officer
- Oliver SchachtExecutive Officer
- Evan JonesDirector
- R. Donald ElseyDirector
- Prabhavathi FernandesDirector
- William E Rhodes IIIDirector
- Mario CrovettoDirector
- Timothy C DecExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $648.3K
- Placement agents
- Alliance Global Partners
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$285.5KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$285.5KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harry D'AndreaDirector
- David M RubinDirector
- Timothy C DecExecutive Officer
- Timothy J.R. HarrisDirector
- Tina S NovaDirector
- Evan JonesExecutive Officer, Director
- Misti UshioDirector
- Offering amount
- $285.5K
- Amount sold
- $285.5K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$110KraisedSep 2017 · 1 investors · BiotechnologyRule 506(b)
▶$110KraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harry D'AndreaDirector
- Tina S NovaDirector
- David M RubinDirector
- Timothy C DecExecutive Officer
- Timothy J.R. HarrisDirector
- Evan JonesExecutive Officer, Director
- Misti UshioDirector
- Offering amount
- $110K
- Amount sold
- $110K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJun 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David M RubinDirector
- Misti UshioDirector
- Tina S NovaDirector
- Harry D'AndreaDirector
- Timothy J.R. HarrisDirector
- Evan JonesExecutive Officer, Director
- Timothy C DecExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $500K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedMay 2016 · 10 investors · BiotechnologyRule 506(b)
▶$7.2MraisedMay 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy C DecExecutive Officer
- Timothy HoweDirector
- Kevin KrenitskyExecutive Officer
- Timothy J.R. HarrisDirector
- Evan JonesExecutive Officer, Director
- Brian G AtwoodDirector
- David M RubinDirector
- Misti UshioDirector
- Laurence R McCarthyDirector
- Harry D'AndreaDirector
- Offering amount
- $10.4M
- Amount sold
- $7.2M
- Sales commissions
- $694.9K
- Placement agents
- Leerink Partners LLC, Maxim Group LLC, Cowen and Company
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.6MraisedJul 2015 · 4 investors · BiotechnologyRule 506(b)
▶$2.6MraisedJul 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evan JonesExecutive Officer, Director
- Kevin KrenitskyExecutive Officer
- Misti UshioDirector
- Timothy J.R. HarrisDirector
- Laurence R McCarthyDirector
- Vadim SapiroExecutive Officer
- Timothy HoweDirector
- Brian G AtwoodDirector
- David M RubinDirector
- Timothy C DecExecutive Officer
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 10
by search overlap
Amgen27 shared keywordsAmgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
Biogen Idec21 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
PepGen19 shared keywordsPepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
Public16 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Robinhood16 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall St15 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Wugen13 shared keywordsAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
Urogen13 shared keywordsUroGen is a biotech company developing treatments for urothelial and specialty cancers using a proprietary sustained-release hydrogel platform technology. The company commercializes approved therapies for bladder and upper tract cancers, with additional candidates in development.
StockTwits12 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TradingView12 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with OpGen for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does OpGen do?
- The page announces the launch of a new fintech arm called CapForce. No further detail about the company's core business is provided on the page.
- Who founded OpGen?
- OpGen was founded by Evan Jones.
- Who are OpGen's investors?
- OpGen's investors include Cross Creek Advisors, Highland Capital Partners.
- How much funding has OpGen raised?
- OpGen has disclosed $65M raised across 13 of its 14 known rounds.
- Where is OpGen headquartered?
- OpGen is headquartered in Gaithersburg, US.